Scilex Holding Company ( SCLX) - Key Metrics
SCLX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $0.91 | -$22.17 | $0.71 | $0.74 |
| 2025Q2 | $0.85 | -$7.42 | $0.61 | $0.61 |
| 2025Q1 | $0.43 | -$2.26 | $0.52 | $0.51 |
| 2024Q4 | $2.14 | -$0.93 | $0.36 | $0.34 |
| 2024Q3 | $3.98 | -$1.21 | $1.41 | $1.37 |
SCLX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | -0.22 |
| 2025Q2 | ? | -0.20 |
| 2025Q1 | ? | -0.96 |
| 2024Q4 | ? | -4.01 |
| 2024Q3 | ? | -6.69 |
SCLX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q3 | 3.74% | ? |
| 2025Q2 | 10.32% | ? |
| 2025Q1 | 5.82% | ? |
| 2024Q4 | 2.30% | ? |
| 2024Q3 | 4.23% | ? |
SCLX
Price: $7.45
52 week price:
Earnings Per Share: -40.46 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 63.3 million